Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET-Type 2: Investigation and Treatment in Type 2 Myocardial Infarction
NCT05419583Completed
- Sponsor
- University of Edinburgh
- Start
- Nov 2022
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of Edinburgh. Primary endpoint: Trial process outcomes: eligibility, approach, consent and randomisation at 90 days. Started Nov 2022; status: completed.
Beyond the preview
Go deeper on NCT05419583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05419583.